Cedric Francois, Chief Executive Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 5,648 shares at $29.52 ($167K) on 2025-01-29, disclosed to the SEC on 2025-01-30.
Seasonal sale ($167k) by Chief Executive Officer — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.52 | 2,824 | $83K | 50.0% |
| 2 | $29.52 | 2,824 | $83K | 50.0% |
| Total | $29.52 avg | 5,648 | $167K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $226K | — | Filing → |
| APLS | SELL | 2025-08-29 | $12.7M | — | Filing → |
| APLS | SELL | 2025-07-18 | $797K | — | Filing → |